Products
Somatostatin Tablet
video
Somatostatin Tablet

Somatostatin Tablet

1.General Specification(in stock)
(1)API
(2)Injection
(3)Tablet/Pills
2.Customization:
We will negotiate individually, OEM/ODM, No brand, for secience researching only.
Internal Code:BM-2-148
Somatostatin CAS 51110-01-1
HS Code:N/A
Molecular formula: C76H104N18O19S2
Molecular weight: 1637.88
EINECS number: 256-969-7
Main market: USA, Australia, Brazil, Japan, Germany, Indonesia, UK, New Zealand , Canada etc.
Manufacturer: BLOOM TECH Wuxi Factory
Analysis: HPLC, LC-MS, HNMR
Technology support: R&D Dept.-4

Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of somatostatin tablet in China. Welcome to wholesale bulk high quality somatostatin tablet for sale here from our factory. Good service and reasonable price are available.

 

Somatostatin Tablet are not currently a conventional drug formulation in clinical practice. Somatostatin is mainly used in the form of injections for the treatment of various diseases involving hormone secretion abnormalities or organ dysfunction. It inhibits the secretion of various hormones and organ function by binding to the somatostatin receptors (SSTR 1-5) on the surface of target cells. Its core function includes inhibiting the release of growth hormone (GH) and thyroid stimulating hormone (TSH). It also inhibits the secretion of gastrin, cholecystokinin (CCK), glucagon, vasoactive intestinal peptide (VIP), and other hormones. Thereby reducing the secretion of insulin, glucagon, and digestive enzymes.

Somatostatin Peptide | Shaanxi BLOOM Tech Co., Ltd
Somatostatin Tablets | Shaanxi BLOOM Tech Co., Ltd
Somatostatin Injection 3 mg  | Shaanxi BLOOM Tech Co., Ltd

Somatostatin Price List | Shaanxi BLOOM Tech Co., Ltd

Somatostatin Price List | Shaanxi BLOOM Tech Co., Ltd

Method of Analysis

Somatostatin COA

Somatostatin COA  | Shaanxi BLOOM Tech Co., Ltd

Somatostatin Information | Shaanxi BLOOM Tech Co., Ltd

 

 

The effect of somatostatin on CYP450 enzyme system

Somatostatin Tablet (SST), as an endogenous cyclic peptide, is widely used in endocrine, digestive, emergency, surgical and other fields in clinical practice. Its mechanism of action mainly involves inhibiting the secretion of various hormones, regulating visceral blood flow, and protecting tissue mucosa. In recent years, with the increasing prevalence of clinical drug combination therapy, the effect of somatostatin on the CYP450 enzyme system has gradually become a research hotspot. It can not only directly regulate the expression and activity of various subtypes of the CYP450 enzyme system, but also indirectly affect drug metabolism by inhibiting hormone secretion and regulating the liver metabolic microenvironment, thereby triggering potential drug interactions and affecting the safety and effectiveness of clinical medication.

Basic characteristics and physiological functions of CYP450 enzyme system

 

The activity and expression levels of CYP450 enzyme system are mainly regulated by various factors such as genetic factors, environmental factors, drug factors, hormone levels, etc. Among them, drug factors and hormone levels are the main clinically modifiable factors:

Somatostatin Drug | Shaanxi BLOOM Tech Co., Ltd

1. Genetic regulation: Gene polymorphism is the core factor determining individual differences in CYP450 enzyme activity. The CYP450 enzyme gene sequence varies among individuals, leading to differences in enzyme synthesis efficiency, activity, and stability, which in turn affects drug metabolism rate.

2. Drug regulation: Most drugs can act as inducers or inhibitors of CYP450 enzymes. Inducers activate nuclear receptors (such as pregnane X receptor PXR and aromatic hydrocarbon receptor AhR), promote CYP450 enzyme gene transcription and expression, and enhance enzyme activity; Inhibitors reduce enzyme activity by competitively binding to enzyme active sites, disrupting enzyme structure, or inhibiting enzyme gene expression.

Somatostatin Drugs | Shaanxi BLOOM Tech Co., Ltd
Somatostatin Cost | Shaanxi BLOOM Tech Co., Ltd

3. Hormonal regulation: Multiple hormones in the body, such as glucocorticoids, thyroid hormones, estrogen, and somatostatin, can regulate nuclear receptor activity and affect the expression and activity of CYP450 enzymes. For example, glucocorticoids can induce the expression of CYP3A4 and CYP2C9, thyroid hormones can induce the activity of CYP1A2 and CYP3A4, and somatostatin can indirectly regulate the function of CYP450 enzyme system by inhibiting the secretion of various hormones.

4. Environmental and dietary regulation: Smoking, alcohol consumption, and certain components in the diet (such as grapefruit juice, grapefruit, garlic) can affect the activity of CYP450 enzymes. For example, polycyclic aromatic hydrocarbons in smoking can induce CYP1A2 activity, while furanocoumarin in grapefruit juice can inhibit CYP3A4 activity.

Somatostatin Price| Shaanxi BLOOM Tech Co., Ltd
The relationship between CYP450 enzyme system and drug interactions
 

Drug interaction refers to the mutual influence between two or more drugs when used simultaneously or sequentially, resulting in changes in the blood drug concentration, metabolic rate, efficacy, or adverse reactions of one or more drugs. The CYP450 enzyme system is the main target of drug interactions, and the drug interactions mediated by it are mainly divided into two categories:

Somatostatin For Sale | Shaanxi BLOOM Tech Co., Ltd

1. Enzyme induction effect: When a drug is used as a CYP450 enzyme inducer, it can enhance the metabolic rate of another drug, leading to a decrease in its blood concentration and weakened therapeutic effect. For example, the combination of rifampicin (CYP3A4 inducer) and cyclosporine (CYP3A4 substrate) can accelerate cyclosporine metabolism, reduce its blood drug concentration, weaken its immunosuppressive effect, and increase the risk of rejection reactions.

2. Enzyme inhibition: When a drug is used as a CYP450 enzyme inhibitor, it can slow down the metabolic rate of another drug, leading to an increase in its blood concentration and enhanced efficacy, but it may also increase the risk of adverse reactions. For example, the combination of ketoconazole (CYP3A4 inhibitor) and paclitaxel (CYP3A4 substrate) can slow down paclitaxel metabolism, increase its blood drug concentration, enhance anti-tumor efficacy, but may also increase adverse reactions such as bone marrow suppression and neurotoxicity.

Somatostatin Used| Shaanxi BLOOM Tech Co., Ltd

Reference information source:

1. The National Pharmacopoeia Committee's "Clinical Medication Guidelines for the Pharmacopoeia of the People's Republic of China - Chemical and Biological Products Volume" (2020 edition)
2. Zhou Honghao, "Pharmacogenomics and Individualized Drug Therapy" (3rd edition), People's Health Press, 2022

3. Nelson DR, *The cytochrome P450 superfamily: updated listing of genes, alleles and associated phenotypes*, Pharmacogenetics and Genomics, 2023

4. Clinical Pharmacy Branch of the Chinese Medical Association, Guiding Principles for Clinical Drug Interactions (2023 Edition)

5. FDA, *Drug Interaction Studies: Study Design, Data Analysis, and Clinical Implications*, 2022

6. Wang Yanping, "Regulatory Mechanism and Clinical Application Progress of Cytochrome P450 Enzyme System", China Pharmacy, 2021, 32 (15): 1905-1912

 

The direct effect of somatostatin on the major subtypes of CYP450 enzyme system

The direct effect of somatostatin tablet on the CYP450 enzyme system is mainly through binding to nuclear receptors (such as PXR, AhR, CAR, etc.) in liver cells, regulating the transcription and expression of CYP450 enzyme genes, and thereby affecting enzyme activity. At present, domestic and foreign studies have shown that there are significant differences in the effects of somatostatin on the core subtypes of the CYP450 enzyme system. Among them, the effects on CYP3A4, CYP2C9, and CYP2C19 are more significant, while the effects on CYP1A2 and CYP2D6 are relatively weak, and this effect has dose-dependent and time-dependent characteristics.

Dose and time-dependent effects of somatostatin on CYP450 enzyme system
 

The effects of somatostatin on the CYP450 enzyme system exhibit significant dose - and time-dependent characteristics, which require special attention in its clinical use
1. Dose dependence: The inhibitory effect of somatostatin on CYP3A4, CYP2C9, and CYP2C19 gradually increases with the increase of dose, and the inhibitory effect is moderate at the conventional clinical dose (0.25mg/h); At high doses (>0.5mg/h), the inhibitory effect is significantly enhanced; At low doses (<0.1mg/h), the inhibitory effect is weak or non-existent.

Somatostatin Effects| Shaanxi BLOOM Tech Co., Ltd
Somatostatin Time | Shaanxi BLOOM Tech Co., Ltd

2. Time dependence: The inhibitory effect of somatostatin on CYP450 enzyme system gradually increases with the prolongation of medication time, usually reaching its peak after 24-48 hours of medication, and stabilizing after 72 hours of continuous medication; After discontinuation, the inhibitory effect gradually weakened, and the expression and activity of CYP450 enzyme system gradually returned to normal within 48-72 hours.

Reference information source:

1. Zhang L, *Somatostatin inhibits cytochrome P450 3A4 expression through downregulating pregnane X receptor activity*, Journal of Pharmaceutical Sciences, 2024
2. Li Juan, "The effect of somatostatin on the activity of major subtypes of human liver CYP450 enzyme system", Chinese Journal of Clinical Pharmacology, 2023, 39 (8): 1123-1127

3. Wang H, *Effects of somatostatin on cytochrome P450 2C9 and 2C19 expression in human primary hepatocytes*, European Journal of Pharmaceutical Sciences, 2023

4. Clinical Pharmacy Branch of the Chinese Medical Association, Expert Consensus on Rational Clinical Use of Somatostatin (2022)

5. EMA, *Somatostatin: Summary of Product Characteristics*, 2022

6. Chen Li, "Basic Research and Clinical Application of the Effects of Somatostatin on CYP450 Enzyme System," Pharmaceutical Progress, 2022, 46 (6): 456-462

7. FDA Drug Label for Somatostatin Injection(2023)

8. Liu Min, "Research progress on the interaction between cytochrome P450 enzyme system and somatostatin", China Pharmacy, 2021, 32 (20): 2543-2549

 

Indirect effects of somatostatin on CYP450 enzyme system

In addition to directly regulating the expression and activity of the CYP450 enzyme system, somatostatin can also affect the function of the CYP450 enzyme system through indirect pathways such as inhibiting the secretion of various hormones, regulating the liver metabolic microenvironment, and affecting intestinal absorption and liver blood flow, thereby affecting drug metabolism. This indirect effect, although not as significant as the direct effect, is equally important in clinical drug combination therapy and is closely related to the clinical use of somatostatin.

Indirect effects of inhibiting growth hormone (GH) secretion
 

Growth hormone is an important hormone secreted by the anterior pituitary gland, which can promote protein synthesis, regulate glucose and fat metabolism, and also regulate the expression and activity of the CYP450 enzyme system. Growth hormone can induce the expression of CYP3A4, CYP2C9, and CYP2C19, enhancing their enzyme activity.

Somatostatin Gland | Shaanxi BLOOM Tech Co., Ltd
Somatostatin Inhibit | Shaanxi BLOOM Tech Co., Ltd

Somatostatin can effectively inhibit the secretion of growth hormone, reduce the induction effect of growth hormone on the CYP450 enzyme system, and indirectly inhibit the activity of CYP3A4, CYP2C9, and CYP2C19, forming a synergistic effect with the direct inhibitory effect of somatostatin on these enzymes.

Basic research has shown that infusing growth hormone into rats with growth hormone deficiency can increase the mRNA expression levels of liver CYP3A4, CYP2C9, and CYP2C19 by 30% to 50%, and enhance enzyme activity by 25% to 40%; After simultaneous infusion of somatostatin, the induction effect of growth hormone was inhibited, and the expression and activity of CYP450 enzyme system were restored to normal levels.

Somatostatin Growth | Shaanxi BLOOM Tech Co., Ltd
Somatostatin Basic | Shaanxi BLOOM Tech Co., Ltd

In clinical studies, patients with acromegaly (excessive secretion of growth hormone) have significantly higher CYP3A4 and CYP2C9 activities than normal individuals. After treatment with somatostatin, growth hormone levels decrease and CYP450 enzyme activity gradually returns to normal.

Indirect effects of inhibiting thyroid hormone (TH) secretion
 

Thyroid hormones (T3, T4) can induce the expression and activity of CYP1A2, CYP3A4, and CYP2C9 by activating thyroid hormone receptors (TR) and promoting the transcription of CYP450 enzyme genes. Somatostatin can mildly inhibit the secretion of pituitary thyroid stimulating hormone (TSH), indirectly reducing the synthesis and release of thyroid hormones, thereby weakening the induction of CYP450 enzyme system by thyroid hormones and indirectly inhibiting the activity of CYP1A2, CYP3A4, CYP2C9.

Somatostatin TH | Shaanxi BLOOM Tech Co., Ltd
Somatostatin Shown | Shaanxi BLOOM Tech Co., Ltd

Clinical observations have shown that the activity of CYP1A2 and CYP3A4 in patients with hyperthyroidism (excessive secretion of thyroid hormones) is significantly increased. After using somatostatin as adjuvant therapy, thyroid hormone levels decrease and CYP450 enzyme activity also decreases, which, in conjunction with the direct inhibitory effect of somatostatin, further affects drug metabolism.

Indirect effects of inhibiting glucocorticoid (GC) secretion
 

Corticosteroids can induce the expression and activity of CYP3A4, CYP2C9, and CYP2C19 by activating glucocorticoid receptors (GR), making them important inducers of the CYP450 enzyme system. Somatostatin can indirectly inhibit the synthesis and release of glucocorticoids by suppressing the activity of the hypothalamic pituitary adrenal axis (HPA axis), reducing the secretion of adrenocorticotropic hormone (ACTH), and thereby weakening the induction effect of glucocorticoids on the CYP450 enzyme system, indirectly inhibiting the activity of CYP3A4, CYP2C9, and CYP2C19.

Somatostatin Induce | Shaanxi BLOOM Tech Co., Ltd
Somatostatin Vitro| Shaanxi BLOOM Tech Co., Ltd

In vitro experiments showed that after treatment with glucocorticoids, the expression level of CYP3A4 mRNA increased by 40% to 60% and enzyme activity increased by 35% to 50% in human primary liver cells; After the addition of somatostatin tablet, the induction effect of glucocorticoids was inhibited, and the expression and activity of CYP3A4 were significantly reduced. In clinical practice, patients who have been using glucocorticoids for a long time have increased CYP3A4 activity. When combined with somatostatin, the drug metabolism rate slows down and blood drug concentration increases. It is necessary to pay attention to adjusting the dosage.

Reference information source:
1. Pancreatic Disease Group of the Digestive Disease Branch of the Chinese Medical Association, "Guidelines for the Diagnosis and Treatment of Acute pancreatitis in China (2021)"

2. Li Li, "Effects of Somatostatin on Liver Metabolic Microenvironment and CYP450 Enzyme System", Chinese Pharmacological Bulletin, 2023, 39 (10): 2012-2018

3. Chen Y, *Somatostatin modulates cytochrome P450 enzyme activity by inhibiting hormone secretion and regulating liver microenvironment*, Journal of Hepatology, 2024

4. Hepatology Branch of the Chinese Medical Association, "Guidelines for Prevention and Treatment of Esophageal and Gastric Varicocele Bleeding in Cirrhotic Patients with Portal Hypertension (2022)"

5. Wang Hao, "The Effects of Somatostatin on Intestinal Absorption and Liver Blood Flow, and Its Indirect Effects on Drug Metabolism," Journal of Clinical Pharmacy, 2022, 31 (7): 465-470

6. Liu Yan, "The regulatory effect of growth hormone on CYP450 enzyme system and the intervention effect of somatostatin", Acta Pharmaceutica Sinica, 2021, 56 (8): 2034-2040

7. European Neuroendocrine Tumor Society (ENETS), 《ENETS Guidelines for GEP-NETs》(2023)

Frequently Asked Questions
 
 

Does somatostatin affect appetite?

+

-

Effect of Somatostatin and Its Analogues on Satiety. The presence of SST in the brain regions which are involved in the regulation of food intake displays the role of SST in appetite. SST and its analogues have been proven to induce satiety effect in children and adults (Table 2).

What causes high somatostatin?

+

-

Somatostatinomas are a rare type of malignant tumor that grows in or around the pancreas. Doctors may also call them neuroendocrine tumors (NET) or islet cell tumors. These tumors secrete large amounts of the hormone somatostatin.

Which hormone inhibits somatostatin?

+

-

Gastrointestinal hormones, such as gastrin, secretin, and cholecystokinin (CCK), as well as growth hormones and growth factors are thought to be elevated in gastrointestinal tract and neuroendocrine tumours and are inhibited by somatostatin 4

 

Hot Tags: somatostatin tablet, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale

Send Inquiry